← FDA DRUG APPROVALS

FDA ANDA · ANDA078641

FAMOTIDINE

Sponsor: MYLAN LABS LTD

APPLICATION
ANDA078641
TYPE
ANDA
ORIGINAL APPROVAL
2008-06-25
LATEST ACTION
2020-09-15
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FAMOTIDINEPrescription
FAMOTIDINE 10MG/ML · INJECTABLE · INJECTION

Approval history

2020-09-15Labeling · Supplement 12 · standardAP
2008-06-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →